The neuroscience market size is USD 39.2 Bn in 2026.
The neuroscience market is projected to grow at a CAGR of 5% by 2033.
The neuroscience market growth drivers include rising prevalence of neurological disorders, increasing R&D investments, and rapid technological advancements in brain research.
North America is a dominating region for the neuroscience market.
Eli Lilly and Company, Pfizer Inc., Novartis AG, Roche Holding AG, and Biogen Inc. are some leading industry players in the neuroscience market.